Physician profile
Michael J Tarbox
NPI 1457363590
$32,633.21
in general payments reported to CMS, 2019-2025
22 companies · $18K in 2025
The $18K reported for 2025 was more than what 97% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $2,477 · 2021: $2,277 · 2022: $659 · 2023: $6,022 · 2024: $2,790 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $14K · Consulting Fee: $9,225 · Food and Beverage: $1,970 · Travel and Lodging: $1,689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $14,000.00 |
| Consulting Fee | $9,225.00 |
| Food and Beverage | $1,970.32 |
| Travel and Lodging | $1,688.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $14,110.17 | 2023-2025 | |
| Treace Medical Concepts, INC. | $13,868.13 | 2020-2025 | |
| Arthrex, INC. | $1,542.24 | 2020 | |
| Linvatec Corporation | $1,143.33 | 2023-2025 | In2bones USA, Biobrace 23mm, Quantum |
| Novus Surgical Solutions LLC | $300.00 | 2020 | |
| Organogenesis INC. | $275.56 | 2021-2024 | Puraply Wound Matrix |
| Depuy Synthes Sales INC. | $190.94 | 2019-2020 | |
| Stryker Corporation | $175.66 | 2019-2022 | |
| Anika Therapeutics, INC. | $149.80 | 2022 | |
| Smith+Nephew, INC. | $117.51 | 2022-2023 | Grafix Pl |
| Abbott Laboratories | $101.54 | 2019-2020 | |
| Flower Orthopedics Coporation | $97.12 | 2021 | |
| Extremity Medical | $92.46 | 2024 | |
| In2bones USA, LLC | $83.69 | 2020-2022 | |
| Ortho Solutions INC | $77.85 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $72.48 | 2023 | Acumed |
| Arthrosurface Incorporated | $65.15 | 2019 | |
| Additive Orthopaedics, LLC | $50.81 | 2019 | |
| Kerecis Limited | $35.94 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Paratek Pharmaceuticals, INC. | $32.88 | 2024 | Nuzyra |
| Pfizer INC. | $31.82 | 2021 | |
| Orthofix Medical, INC. | $18.13 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Tarbox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.